葡萄糖细胞增生和瘤:一种最近公认的内分泌受体疾病
Bence Sipos1,2, Günter Klöppel3
1Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tubingen, Tübingen, Germany.
Endocrine-related cancer
|June 1, 2023
概括
葡萄糖细胞增生和瘤 (GCHN) 是一种罕见的内分泌疾病,由失活葡萄糖受体 (GCGR) 基因突变引起. 这种遗传缺陷导致胰腺神经内分泌瘤,尽管葡萄糖水平高.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 葡萄糖细胞增生和瘤 (GCHN) 是一种罕见的内分泌疾病.
- 形态学在2006年首次被描述,遗传原因在2009年被确定.
- 这种疾病是由于葡萄糖受体 (GCGR) 基因中的失活突变引起的.
研究的目的:
- 总结一下目前对GCHN的理解.
- 突出GCGR突变,代谢功能障碍和瘤发展之间的联系.
- 讨论这种罕见疾病的临床和遗传特征.
主要方法:
- 审查关于GCHN的现有文献.
- 分析涉及GCGR淘汰赛小鼠的研究.
- 遗传缺陷与观察到的临床和代谢表型的相关性.
主要成果:
- GCGR基因突变会影响葡萄糖的信号传递,主要发生在肝脏中.
- 血清氨基酸的升高与刺激葡萄糖细胞增生有关.
- 这一过程可能导致潜在的恶性胰腺神经内分泌瘤.
- 患者表现出高葡萄糖水平,但没有葡萄糖瘤综合征.
结论:
- GCHN是一种自体逆性遗传性疾病.
- 了解 GCGR 途径对于 GCHN 发病过程至关重要.
- 需要进一步的研究来探索GCHN的治疗策略.
相关概念视频
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Glucagon-like Receptor Agonists
372
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
372
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Hormones Regulating Blood Glucose
3.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K


